The Anticancer Potential of Peroxisome Proliferator‐Activated Receptor Antagonists

By  

CHEMMEDCHEM, Vol. 13, Iss. 3, 2018-02 ,pp. : 209-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator‐Activated Receptor Gamma in Rats

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3049-3059

John Wiley & Sons Inc

Access to resources Recommend Favorite

In‐vivo antioxidant and anti‐inflammatory activity of rosiglitazone, a peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) agonists in animal model of bronchial asthma

By  

JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol. 67, Iss. 10, 2015-10 ,pp. : 1421-1430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Friedelin and lanosterol from Garcinia prainiana stimulated glucose uptake and adipocytes differentiation in 3T3-L1 adipocytes

By Susanti Deny  

Natural Product Research, Vol. 27, Iss. 4-5, 2013-03 ,pp. : 417-424

Taylor & Francis Ltd

Access to resources Recommend Favorite

Mass spectrometry of doping preparations of a new generation: Peroxisome proliferator-activated receptor agonists

By Dikunets M.   Virus E.   Semenistaya E.   Sobolevsky T.   Rodchenkov G.  

Journal of Analytical Chemistry, Vol. 65, Iss. 13, 2010-12 ,pp. : 1411-1419

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite